NasdaqGS:TXGLife Sciences
A Look At 10x Genomics (TXG) Valuation After The Atera Spatial Biology Platform Launch
10x Genomics (TXG) is in focus after unveiling its Atera spatial biology platform at the AACR Annual Meeting, pairing whole transcriptome and single cell tissue analysis with new cloud and sample submission services.
See our latest analysis for 10x Genomics.
The Atera launch comes after a strong run, with a 28.58% year to date share price return and a very large 1 year total shareholder return, although the 3 and 5 year total shareholder returns remain sharply negative, which can temper...